Brief: Biomarin Pharmaceutical Inc Reaffirming Its Long-Term Financial Guidance And Outlook That It Presented During Investor Day
24/09/2024 13:39
Sept 24 (Reuters) - Biomarin Pharmaceutical Inc
BMRN.O :
* BIOMARIN PHARMACEUTICAL INC: REAFFIRMING ITS LONG-TERM
FINANCIAL
GUIDANCE AND OUTLOOK THAT IT PRESENTED DURING INVESTOR DAY
Source text for Eikon: ID:n0001193125-24-224139
Further company coverage: BMRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioMarin Pharmaceutical
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Biomarin Pharmaceutical Expects Q3 2026 Pre-Tax Charges Of $283 Million For Bought Ipr&D Expense
Brief: Biomarin Appoints Cara Bauer As Chief People Officer
Brief: Biomarin Pharmaceutical Enters Settlement And License Agreement With Ascendis Pharma On Sept 24, 2026
U.S. STOCKS ON THE MOVE-GitLab, California utilities, Herbalife